Lutetium-177 Dotatate Peptide Receptor Radionuclide Therapy in metastatic pheochromocytoma and paraganglioma: Experience in our center

被引：0
作者：
Negre, M. [1 ]
Guardeno, R. [1 ]
Biarnes, J. [1 ]
Recasens, M. [1 ]
Rubio, A. [1 ]
机构：
[1] Hosp Univ Girona Dr Josep Trueta, Girona, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2024年 / 36卷
关键词：
prrt; 177lu-dotatate; metastatic paraganglioma; metastatic pheochromocytoma;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H13
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
[31]   Comparison of commercial dosimetric software platforms in patients treated with 177Lu-DOTATATE for peptide receptor radionuclide therapy [J].
Mora-Ramirez, Erick ;
Santoro, Lore ;
Cassol, Emmanuelle ;
Ocampo-Ramos, Juan C. ;
Clayton, Naomi ;
Kayal, Gunjan ;
Chouaf, Soufiane ;
Trauchessec, Dorian ;
Pouget, Jean-Pierre ;
Kotzki, Pierre-Olivier ;
Deshayes, Emmanuel ;
Bardies, Manuel .
MEDICAL PHYSICS, 2020, 47 (09) :4602-4615
[32]   Glucagonoma Pancreatic Neuroendocrine Tumor Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy [J].
Makis, William ;
McCann, Karey ;
Riauka, Terence A. ;
McEwan, Alexander J. B. .
CLINICAL NUCLEAR MEDICINE, 2015, 40 (11) :877-879
[33]   Retreatment with Peptide-Receptor Radionuclide Therapy: Effects on Long-Term Survival, Renal and Bone Marrow Toxicity Using Yttrium-90 vs. Lutetium-177 [J].
Machta, J. ;
Caplin, M. ;
Toumpanakis, C. ;
Mohmaduvesh, M. ;
Garcia-Hernandez, J. ;
Navalkissoor, S. .
NEUROENDOCRINOLOGY, 2016, 103 :94-94
[34]   Evaluation of Kidney Dose in Neuroendocrine Tumors Patients after Peptide Receptor Radionuclide Therapy using 177Lu-DOTATATE [J].
Hidayati, N. R. ;
Poon, A. ;
Willowson, K. ;
Eslick, E. ;
Ryu, H. ;
Bailey, D. L. .
ATOM INDONESIA, 2019, 45 (03) :147-152
[35]   The utility of 68Ga-DOTATATE PET/CT in localizing primary/metastatic pheochromocytoma and paraganglioma in children and adolescents - a single-center experience [J].
Jaiswal, Sanjeet Kumar ;
Sarathi, Vijaya ;
Malhotra, Gaurav ;
Hira, Priya ;
Shah, Ravikumar ;
Patil, Virendra A. ;
Dalvi, Abhay ;
Prakash, Gagan ;
Lila, Anurag R. ;
Shah, Nalini S. ;
Bandgar, Tushar .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (01) :109-119
[36]   NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy [J].
Hope, Thomas A. ;
Bodei, Lisa ;
Chan, Jennifer A. ;
El-Haddad, Ghassan ;
Fidelman, Nicholas ;
Kunz, Pamela L. ;
Mailman, Josh ;
Menda, Yusuf ;
Metz, David C. ;
Mittra, Erik S. ;
Pryma, Daniel A. ;
Reidy-Lagunes, Diane L. ;
Singh, Simron ;
Strosberg, Jonathan R. .
JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) :222-227
[37]   Eruption of Metastatic Paraganglioma After Successful Therapy with 177Lu/90Y-DOTATOC and 177Lu-DOTATATE [J].
Wolf, Katherine, I ;
AbhishekJha ;
van Berkel, Anouk ;
Wild, Damian ;
Janssen, Ingo ;
Millo, Corina M. ;
Janssen, M. J. R. ;
Gonzales, Melissa K. ;
Timmers, Henri J. K. M. ;
Pacak, Karel .
NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 53 (03) :223-230
[38]   Eruption of Metastatic Paraganglioma After Successful Therapy with 177Lu/90Y-DOTATOC and 177Lu-DOTATATE [J].
Katherine I. Wolf ;
Abhishek Jha ;
Anouk van Berkel ;
Damian Wild ;
Ingo Janssen ;
Corina M. Millo ;
M. J. R. Janssen ;
Melissa K. Gonzales ;
Henri J. K. M. Timmers ;
Karel Pacak .
Nuclear Medicine and Molecular Imaging, 2019, 53 :223-230
[39]   Repeat Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors: A NET Center of Excellence Experience [J].
Grewal, Udhayvir S. ;
Loeffler, Bradley T. ;
Paschke, Alexander ;
Dillon, Joseph S. ;
Chandrasekharan, Chandrikha .
JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) :1165-1170
[40]   Should peptide receptors radionuclide therapy (PRRT) be considered as a treatment of choice in functioning metastatic insulinomas? A review of literature and our center experience [J].
Matti Antonella ;
Olivari Laura ;
Diodato Stefania ;
Doraku Joniada ;
Salgarello Matteo .
Clinical and Translational Imaging, 2022, 10 :425-433
12345